Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT) is a global company in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences. This news page aggregates announcements, press releases, and corporate updates related to Waters, giving readers a focused view of developments that affect the company and its markets.
Investors and industry professionals can use this feed to follow Waters’ product launches, financial results, and strategic initiatives. Recent news has highlighted new technologies such as the Xevo Charge Detection Mass Spectrometer (CDMS), which Waters describes as enabling direct mass detection for large biomolecules relevant to next-generation therapeutics, and a Charged Aerosol Detector designed for use with the company’s Empower chromatography data system. These announcements illustrate how Waters is addressing analytical challenges in pharmaceuticals, biotherapeutics, food analysis, and environmental testing.
The news stream also features quarterly earnings releases, where Waters reports sales performance, instrument and recurring revenue trends, and commentary from management. In addition, Waters issues updates on investor conference presentations and on the planned combination with BD’s Biosciences & Diagnostic Solutions business via a Reverse Morris Trust transaction, as described in its press releases and Form 8-K filings.
By reviewing Waters-related news in one place, readers can track themes such as instrument replacement cycles, adoption of new chromatography and mass spectrometry products, and the company’s expansion into adjacencies like bioseparations, bioanalytical characterization, and multiplex diagnostics. Bookmark this page to monitor ongoing disclosures and media releases that shape the narrative around WAT stock and Waters’ role in regulated, high-volume testing and scientific markets.
Waters Corporation has launched the Extraction+ Connected Device, which automates solid phase extraction (SPE) methods, significantly reducing sample preparation time by up to four hours per sample set. This innovation, compatible with the Andrew+ Pipetting Robot and controlled through OneLab Software, minimizes user variability and enhances assay reproducibility. The device is now available globally, marking a step forward in laboratory efficiency for biological, food, forensic, and environmental applications.
Waters Corporation (NYSE:WAT) announced a multi-year investment of up to €6 million, supported by IDA Ireland, to enhance its research and development operations in Wexford, Ireland. This expansion aims to create new scientific jobs and focus on clinical diagnostic solutions. Waters commemorates its 25th anniversary in Ireland, reinforcing its commitment to advancing mass spectrometry technologies for early disease detection. The Wexford facility is vital for manufacturing in-vitro diagnostic systems and aims to improve diagnostic accuracy for various medical conditions.
Waters Corporation (NYSE:WAT) will announce its Q3 2022 financial results in a conference call on November 1, 2022, at 8:00 a.m. ET. The presentation will be accessible through a live webcast on Waters’ investor relations website. A replay option will be available until November 15, 2022, at midnight ET. Waters Corporation has over 60 years of experience in analytical instruments and software, serving various sectors, including life sciences and materials, with a workforce of more than 7,800 employees.
Waters Corporation (NYSE:WAT) has launched advanced powder rheology capabilities for its HR Rheometer, enhancing its versatility in characterizing liquids, solids, and powders. The new SmartSwap™ tooling allows quick transitions between liquid and powder measurements in just 10 seconds, improving sample preparation speed by three times compared to competitors. This innovative technology supports industries like lithium-ion batteries and pharmaceuticals, ensuring accurate data for optimizing materials and processing. The powder rheology accessory is available for existing or new HR Rheometers.
Waters Corporation announced the opening of a new $215M Precision Chemical Manufacturing Facility in location value="LU/us.ma.tauntn"Taunton, Massachusetts, achieving LEED certification from the org value="ACORN:1719435565"U.S. Green Building Council. This facility will enhance production for essential products in the development and testing of vaccines and medicines, creating 25 new jobs and significantly increasing operational efficiency. Waters' facility is the first LEED-certified chemical manufacturing plant in Massachusetts, promoting environmental sustainability in its operations.
Waters Corporation (NYSE:WAT), under CEO Udit Batra, will join the Bank of America 2022 Global Healthcare Conference in London on September 14, 2022, at 9:05 AM BST. Investors can tune into the event via a live webcast on the company’s investor relations website. A recorded replay will be accessible for 30 days post-event. With over 60 years of experience, Waters is a leader in analytical instruments and software, employing 7,800 staff across 35 countries and operating 14 manufacturing facilities.
Waters Corporation (NYSE: WAT) reported second-quarter 2022 sales of $714 million, a 5% increase from the previous year and 10% in constant currency. Instrument sales rose 12% in constant currency, driven by robust performance across product lines. Recurring revenues grew by 8% in constant currency. GAAP EPS was $2.72 and non-GAAP EPS increased 6% to $2.75. For the first half of 2022, sales were $1,405 million, up 9% as reported, with full-year 2022 guidance raised, anticipating 9.5% to 10.5% constant currency sales growth.
Waters Corporation (NYSE:WAT) announced its collaboration with the Plant Protein Innovation Center at the University of Minnesota to advance plant-based protein science. The partnership will leverage Waters’ ACQUITY Premier UPLC System to establish a standard workflow for amino acid analysis, vital for evaluating alternative proteins. With projections showing that plant proteins could secure an 11% market share by 2035, Waters aims to support the transition to healthier and sustainable dietary options while addressing climate change and food security challenges.
Waters Corporation (NYSE:WAT) will host its Q2 2022 financial results conference call on August 2, 2022, at 8:00 a.m. ET. The event will be accessible via a live webcast on Waters' investor relations site, with a replay available until August 16, 2022. Waters, a leader in analytical instruments and software, has been innovating in chromatography and mass spectrometry for over 60 years, employing more than 7,800 people and operating in over 35 countries.
Waters Corporation (NYSE:WAT) has partnered with BioInfra to launch the ASEAN Academy for Bioanalysis in South Korea. This training facility aims to equip scientists with essential bioanalytical skills required for drug discovery and development, addressing the increasing demand for low-cost generic drugs in Southeast Asia. The academy will focus on bioequivalence trials, enhancing the region's scientific competitiveness and pharmaceutical research quality, ultimately benefiting the growing elderly population facing health challenges.